The animal health company has three pairs of tickets to the performance at the SSE Arena Wembley to celebrate the company's Equine Locomotion range.
The online competition launches on July 27 at www.dechra.co.uk/equinecompetition with entrants answering a series of questions that will be released each week in connection with Dechra products that are designed to treat equine locomotion disorders.
They will also have to collect 10 letters that will be revealed over three weeks to form the final answer. The closing date for entries is August 19.
Entry forms are being posted to UK equine practices and will also be available at www.dechra.co.uk/equinecompetition.
Emma Jennings, Brand Manager at Dechra said: “Lameness in horses is an important health and welfare problem. Horses suffering from arthritis, tendonitis or bursitis need to be diagnosed to uncover the exact cause of the lameness and then treated appropriately.
“Equine Locomotion is a comprehensive range of treatments for everything from joint dysfunction and musculoskeletal disorders to inflammatory swellings and the bone resorptive processes of the navicular bone.”
The Equine Locomotion range includes HY-50® Vet, an injection to treat lameness, Intra-Epicaine®, which is a mepivacaine hydrochloride for infiltration, nerve block, intra-articular and epidural anaesthesia, Equipalazone® in powder, paste and injection format to treat musculoskeletal disorders and Osphos® for the alleviation of clinical forelimb lameness associated with the bone resorptive processes of the navicular bone.